Home   Business   Life Science

Subscribe Now

Life Science




F-star strikes antibody deal worth potential $1.35bn with Janssen Biotech

F-star strikes antibody deal worth potential $1.35bn with Janssen Biotech

F-star strikes antibody deal worth potential $1.35bn with Janssen Biotech

The Babraham Research Campus biopharma will receive upfront fees of $17.5m.


BenevolentAI aims to enter clinic in 2023 with candidate for novel ulcerative colitis target

BenevolentAI aims to enter clinic in 2023 with candidate for novel ulcerative colitis target

BenevolentAI aims to enter clinic in 2023 with candidate for novel ulcerative colitis target

The novel biological target identified using AI has been experimentally validated.

1

Illumina offers insight into world of DNA sequencing for 35 interns at Granta Park

Illumina offers insight into world of DNA sequencing for 35 interns at Granta Park

Illumina offers insight into world of DNA sequencing for 35 interns at Granta Park

They are working alongide industry experts on real-time projects.


‘Ground-breaking’ breast cancer trial results fuel blockbuster drug hopes for AstraZeneca

‘Ground-breaking’ breast cancer trial results fuel blockbuster drug hopes for AstraZeneca

‘Ground-breaking’ breast cancer trial results fuel blockbuster drug hopes for AstraZeneca

It is working with Daiichi Sankyo on Enhertu.


AstraZeneca to invest in Imperial College London spin-off VaxEquity and build $360m manufacturing facility in Ireland

AstraZeneca to invest in Imperial College London spin-off VaxEquity and build $360m manufacturing facility in Ireland

AstraZeneca to invest in Imperial College London spin-off VaxEquity and build $360m manufacturing facility in Ireland

VaxEquity could receive up to $195m.


CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology

CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology

CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology

The company recently secured £890,000 from Cambridge-based CMS Ventures.


AI used to predict Covid-19 patients’ oxygen needs by NVIDIA and hospitals including Addenbrooke’s

AI used to predict Covid-19 patients’ oxygen needs by NVIDIA and hospitals including Addenbrooke’s

AI used to predict Covid-19 patients’ oxygen needs by NVIDIA and hospitals including Addenbrooke’s

They used federated learning to train an algorithm without sharing data.


Metrion Biosciences plots global growth by doubling its space with new Granta Park headquarters

Metrion Biosciences plots global growth by doubling its space with new Granta Park headquarters

Metrion Biosciences plots global growth by doubling its space with new Granta Park headquarters

It intends to expand in the US in 2022.


PetMedix closes £27m round close to propel pipeline through the clinic

PetMedix closes £27m round close to propel pipeline through the clinic

PetMedix closes £27m round close to propel pipeline through the clinic

Two new investors have joined.


AstraZeneca and European Commission end legal dispute over supply of Covid-19 vaccine

AstraZeneca and European Commission end legal dispute over supply of Covid-19 vaccine

AstraZeneca and European Commission end legal dispute over supply of Covid-19 vaccine

It had been heading for the courts.


Cambridge Clinical Laboratories to offer prostate cancer gene test Prostatype to UK healthcare facilities

Cambridge Clinical Laboratories to offer prostate cancer gene test Prostatype to UK healthcare facilities

Cambridge Clinical Laboratories to offer prostate cancer gene test Prostatype to UK healthcare facilities

Milton-based CCL has teamed up with Prostatype Genomics.


Excivion confirms success of dengue and Zika antibody tests with ‘invisibility cloak’ technology

Excivion confirms success of dengue and Zika antibody tests with ‘invisibility cloak’ technology

Excivion confirms success of dengue and Zika antibody tests with ‘invisibility cloak’ technology

The novel tests could be used to inform vaccination practice.


Mission Therapeutics earns $20m milestone payment from AbbVie in Alzheimer’s and Parkinson’s collaboration

Mission Therapeutics earns $20m milestone payment from AbbVie in Alzheimer’s and Parkinson’s collaboration

Mission Therapeutics earns $20m milestone payment from AbbVie in Alzheimer’s and Parkinson’s collaboration

Two targets have been identified.

5

Maggot enzyme in wound-cleaning product Aurase powers Cambridge biotech start-up SolasCure to £15m Series A raise

Maggot enzyme in wound-cleaning product Aurase powers Cambridge biotech start-up SolasCure to £15m Series A raise

Maggot enzyme in wound-cleaning product Aurase powers Cambridge biotech start-up SolasCure to £15m Series A raise

Industry veterans have backed the company.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More